Generated by AI
Elanco Animal Health Incorporated is an animal health company focused on developing, manufacturing, and marketing products for pets and farm animals. Its portfolio includes treatments and preventive solutions for parasitic control, dermatology, pain management, vaccines, and other therapeutic areas used in companion animals and livestock. The company serves veterinarians, pet owners, farmers, and producers across a wide range of species, including dogs, cats, cattle, poultry, swine, and sheep. Elanco Animal Health Incorporated also offers products used in food-animal health and production settings, supporting disease prevention and animal wellbeing in everyday care and commercial agriculture. Headquartered in Indianapolis, Indiana, Elanco Animal Health Incorporated operates as a diversified participant in the global animal health market, with a broad product mix spanning companion animal and farm animal care.
Website450 Elanco Circle
Indianapolis, IN, 46221
United States
The latest articles about ELAN.
Shares of animal health company Elanco (NYSE:ELAN) jumped 9.5% in the afternoon session after the company reported third-quarter 2026 results and raised its full-year guidance.
Elanco's pricing held firm in Q3 while rivals discounted, a choice that tests whether proprietary products can continue to win share without cutting prices.
Summary of May 7's posts. Generated by AI.
No summary yet.
Summary of Aug 9's posts. Generated by AI.
Summary of May 7's posts. Generated by AI.
Investors talking about ELAN also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.